ProShares Trust ProShares Ultra Nasdaq Biotechnology
BIB
Closed
$110.99
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
BIB was created on 2010-04-07 by ProShares. The fund's investment portfolio concentrates primarily on health care equity. BIB provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ.
Company
ProShares
Asset class
Equity
Inception date
2010
Investment segment
Health Care
ISIN
US74347R2141
Website
Key stats
Open
$107.97
Volume
10.32K
AUM
$89.21M
Prev. close
$108.49
Expense ratio
0.95%
P/E
0.00
$107.57
Day’s Range
$110.99
$73.78
52W Range
$110.19
What’s in the fund
2
Total sectors
Health Care
25.04%
Others
74.96%
Returns
Performance
_
Difference
_
ProShares Trust ProShares Ultra Nasdaq Biotechnology
Mar
31
Dividends
The last payment date was Mar 31, 2026
Div. per Share
$0.01
Div. Yield
0.01%
Div. Growth YoY
-94.70%
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply